MedPath

How Do We Ultrasound-Guided Popliteal Approach Sciatic Nerve Block?

Not Applicable
Recruiting
Conditions
Adult
Anesthesia Injection Site
Regional Anesthesia Morbidity
Interventions
Other: Subparaneural Injection (Grup S), Block
Other: Interneural Injection (Grup I), Block
Registration Number
NCT06372691
Lead Sponsor
Ankara City Hospital Bilkent
Brief Summary

The aim of this prospective, randomized, observer-blind study to compare subparaneural approach injection with interneural approach injection in popliteal sciatic nerve blocks.

Detailed Description

The study will involve American Society of Anesthesiologists Physical Status Classification (ASA) III or IV risk group patients, 18 years of age or older, who will undergoing foot, ankle, or toe amputation.

Supparaneural injection (Group S) and interneural injection method (Group I) will the two research groups to which patients were randomly allocated.

Every 5 minutes following LA injection, an investigator who will blind to randomization will assess the sensory and motor blockage in the operated foot. The study will documented the operative time, block characteristics, such as the duration of block administration, sensory and motor block start and regression times, the time of extra analgesic required, and the occurrence of complications.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
809
Inclusion Criteria
  • 18 years and over
  • Planned foot, ankle or toe amputation
  • ASA III-IV risk group
  • Patients who agreed to be included in the study
Exclusion Criteria
  • People with neurological and psychiatric diseases
  • Using opioids or another analgesic for chronic pain
  • Allergic to local anesthetics
  • Pregnant or breastfeeding
  • Those with infection or sepsis in the application area
  • Patients who did not agree to be included in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Subparaneural Injection (Group S)Subparaneural Injection (Grup S), BlockThe position of the patients will be prone.The skin will be cleaned according to asepsis and antisepsis rules.After preparing the USG a high-frequency linear array transducer under sterile conditions,we will be positioned it transversely in the popliteal fossa.After visualizing the artery,its hyperechoic nerves will be founded superficially.The sciatic nerve will be identified proximally to visualize where the TN and CPN eventually come together to form the sciatic nerve and separate distally where the CPN moves laterally and the TN remains medially.Once the nerves began to separate,they will be scanned until a figure 8 or pant leg image will be obtained.Using the in-plane technique under ultrasonography guidance, injection will be applied to the subparaneural area in Group S.1 ml of LA solution was injected for the purpose of verifying proper needle insertion.A standard dose of 15 mL bupivacaine 0.5% and 5mg/mL local anesthetic was used accompanied by a 20G,12mm block needle.
Interneural Injection (Group I)Interneural Injection (Grup I), BlockThe position of the patients will be prone.The skin will be cleaned according to asepsis and antisepsis rules.After preparing the USG a high-frequency linear array transducer under sterile conditions, we will be positioned it transversely in the popliteal fossa.After visualizing the artery, its hyperechoic nerves will be founded superficially.The sciatic nerve will be identified proximally to visualize where the TN and CPN eventually come together to form the sciatic nerve and separate distally where the CPN moves laterally and the TN remains medially.Once the nerves began to separate, they will be scanned until a figure 8 or pant leg image will be obtained.Using the in-plane technique under ultrasonography guidance, injection will be applied to the interneural area in Group I.1 ml of LA solution was injected for the purpose of verifying proper needle insertion.A standard dose of 15 mL bupivacaine 0.5% and 5mg/mL local anesthetic was used accompanied by a 20 G, 12mm block needle.
Primary Outcome Measures
NameTimeMethod
Onset TimeTime from the moment the block is made to the moment it starts, within the first half hour

Onset time will be defined as the moment when it is determined that the block is successful.

Secondary Outcome Measures
NameTimeMethod
Block Execution Times1-10 minutes

The time from the moment the block starts to the moment the transaction ends.

Hemodynamic Effects Of The Block0th minutes, 5th minutes,10th minutes,15th minutes,20th minutes,25th minutes,30th minutes,35th minutes,40th minutes,45th minutes,50th minutes,55th minutes and 60th minutes and then at 1-hour intervals and 15th minutes,30th minutes

Noninvasive systolic and diastolic blood pressure

Regression Time Of Sensory and Motor BlockWithin 24 hours

When the block starts to come back.

Total Block TimesWithin 24 hours

How long the block took in total.

Adverse Effects to AnesthesiaDuring the block period, within 24 hours

hypotension, agitation, nausea, vomiting, dizziness

Effects Of The Block On Heart Rate0th minutes, 5th minutes,10th minutes,15th minutes,20th minutes,25th minutes,30th minutes,35th minutes,40th minutes,45th minutes,50th minutes,55th minutes and 60th minutes and then at 1-hour intervals and 15th minutes,30th minutes

Heart rate

Effects Of The Block On Peripheral Pulse Oximetry0th minutes, 5th minutes,10th minutes,15th minutes,20th minutes,25th minutes,30th minutes,35th minutes,40th minutes,45th minutes,50th minutes,55th minutes and 60th minutes and then at 1-hour intervals and 15th minutes,30th minutes

Peripheral pulse oximetry

Need for Multiple Injections Owing to Insufficient AnesthesiaWithin 24 hours

How many blocks should be made.

Additional Rescue AnalgesicWithin 24 hours

Analgesic use status.

Trial Locations

Locations (1)

Ankara Bilkent City Hospital

🇹🇷

Ankara, Çankaya, Turkey

© Copyright 2025. All Rights Reserved by MedPath